Cargando…
CD19嵌合抗原受体T细胞对不同淋巴瘤细胞杀伤活性的研究
OBJECTIVE: To investigate the specific cytotoxicities of the second and third generations of chimeric antigen receptor (CAR) -engineered T cells (CAR-T) on different lymphomas. METHODS: CAR-Ts were prepared by lentivirus packaging and infection of T cells. CCK-8, ELISA and Lactate dehydrogenase cyto...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364971/ https://www.ncbi.nlm.nih.gov/pubmed/29166735 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.004 |
Ejemplares similares
-
血液肿瘤嵌合抗原受体自然杀伤细胞治疗研究进展
Publicado: (2022) -
PD-1抑制剂Nivolumab对CD19嵌合抗原受体T细胞体外增殖和杀伤活性的影响
Publicado: (2018) -
嵌合抗原受体T细胞治疗B细胞淋巴瘤研究进展
Publicado: (2018) -
CD19嵌合抗原受体T细胞制备条件优化及其体内外杀伤作用研究
Publicado: (2022) -
嵌合抗原受体T细胞联合治疗策略在淋巴瘤中的研究探索
Publicado: (2022)